MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2023-24)
- Udyam number
- UDYAM-UP-55-0001071
Eligens Pharmaceuticals Private Limited
Eligens Pharmaceuticals Private Limited - chemicals in Lucknow, Uttar Pradesh, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹19.06 Lakh
▲ 29% YoY
Net loss · FY 2025
₹2,171
Net margin -0.1%
EBITDA · FY 2025
₹4,212
EBITDA margin 0.2%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
7 yrs
Est. 2019
Directors on board
2
As per MCA filings
Active GSTINs
1
GST registered
About Eligens Pharmaceuticals Private Limited
Data last updated:
Eligens Pharmaceuticals Private Limited is a private limited company based in Lucknow, Uttar Pradesh, India. It operates in the fine chemicals and other chemical products segment of the chemicals sector. It was incorporated on 05 March 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Kanpur, under CIN U24299UP2019PTC114342. Its GSTIN is 09AAFCE4028A1Z3 (Uttar Pradesh).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Saurabh Kumar Rai and Devesh Kumar Rai.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 5/288 Vipul Khand Gomti Nagar, Lucknow, Uttar Pradesh, India – 226010.
As per the financials filed for FY 2025, the company reported a revenue of ₹19.06 Lakh, a growth of 29% compared to the previous year. For the same year it recorded a net loss of ₹2,171 (net margin -0.1%) and EBITDA of ₹4,212 (EBITDA margin 0.2%). Revenue has grown at a compounded annual rate (CAGR) of 9% over three years.
Eligens Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-UP-55-0001071).
Company details
CIN U24299UP2019PTC114342
Registration Number 114342
Incorporation Date 05 March 2019
ROC Kanpur
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
MSME Classification Micro
Udyam Registration UDYAM-UP-55-0001071
Recognitions & Rankings of Eligens Pharmaceuticals
Contact details
Eligens Pharmaceuticals Private Limited's registered office is in Lucknow, Uttar Pradesh. Its e-mail address is in the company report.
- Email
- Registered Address5/288 Vipul Khand Gomti Nagar, Lucknow, Uttar Pradesh, India – 226010
- IndustryChemicals, Fine Chemicals And Other Chemical Products, Manufacturing, Other Chemical Product
To see the full contact details of Eligens Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Eligens Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Eligens Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Eligens Pharmaceuticals Private Limited, buy the company report.
Financials of Eligens Pharmaceuticals Private Limited
FY 2025 filings availableEligens Pharmaceuticals Private Limited reported revenue of ₹19.06 Lakh (up 29% YoY) for FY 2025.
Revenue · FY 2025
₹19.06 Lakh ▲ 29%
Net loss · FY 2025
₹2,171 margin -0.1%
EBITDA · FY 2025
₹4,212 margin 0.2%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 29%
3 years · compounded
▲ 9%
EBITDA CAGR growth
1 year
▲ 16%
3 years · compounded
▲ 56%
5 years · compounded
▲ 19%
Revenue has grown at a compounded annual rate (CAGR) of 9% over three years, including 29% growth in the latest year. EBITDA rose 16% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹4,212 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹2,171 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 0.2% | ||||
| Net Profit Margin | -0.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Eligens Pharmaceuticals Private Limited, buy the company report.
Board of directors of Eligens Pharmaceuticals Private Limited
Eligens Pharmaceuticals has 2 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Saurabh Kumar Rai | Director | 05 Mar 2019 | 7 Years 8 Months | Current |
| Devesh Kumar Rai | Director | 05 Mar 2019 | 7 Years 8 Months | Current |
Peer comparison
Eligens Pharmaceuticals Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Ado Pharmaceuticals Private Limited | ₹19.12 Lakh (FY 2024) | 47.0% | Mohali, Punjab, India | |||
| Arvikha Pharmaceuticals Private Limited | ₹19.09 Lakh (FY 2025) | 15.0% | Kolkata, West Bengal, India | |||
| Dablap Pharmaceuticals Private Limited | ₹19.07 Lakh (FY 2025) | 38.0% | Delhi, India | |||
| Eligens Pharmaceuticals Private Limitedthis company | ₹19.06 Lakh (FY 2025) | -₹2,171 | -0.1% | 29.0% | Lucknow, Uttar Pradesh, India | |
| Pinakin Pharmaceuticals Private Limited | ₹19.03 Lakh (FY 2024) | 3.0% | Vadodara, Gujarat, India |
To see the full peer comparison of Eligens Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Eligens Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Eligens Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Eligens Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AAFCE4028A1Z3 | Uttar Pradesh | Active | 29 Oct 2021 |
To see the full GST registrations and return filing status of Eligens Pharmaceuticals Private Limited, buy the company report.
Recent activity
Eligens Pharmaceuticals Private Limited has 2 board changes on record since 2019: 2 appointments. The latest: Devesh Kumar Rai was appointed as Director on 05 Mar 2019.
AGM
Eligens Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Eligens Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Kanpur.
Appointed
Devesh Kumar Rai was appointed as Director.
Appointed
Saurabh Kumar Rai was appointed as Director.
Incorporation
05 Mar 2019
Eligens Pharmaceuticals Private Limited was registered on 05 Mar 2019 with Roc Kanpur & aged 7 years 8 months as per MCA records.
Frequently asked questions
Eligens Pharmaceuticals is an active private limited company based in Lucknow, Uttar Pradesh, India. The company works in fine chemicals and other chemical products, within the chemicals industry. It was incorporated on 05 March 2019 (7+ years old) and is registered under CIN U24299UP2019PTC114342.
Eligens Pharmaceuticals has 2 current directors:
- Saurabh Kumar Rai - Director
- Devesh Kumar Rai - Director
The latest financial statements of Eligens Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2019 are in the company report.
The GSTIN of Eligens Pharmaceuticals is 09AAFCE4028A1Z3, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of Eligens Pharmaceuticals is U24299UP2019PTC114342. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Eligens Pharmaceuticals was incorporated on 05 March 2019, making it 7+ years old. It is registered with the Registrar of Companies, Kanpur.
The peers of Eligens Pharmaceuticals by revenue are Ado Pharmaceuticals Private Limited, Arvikha Pharmaceuticals Private Limited, Dablap Pharmaceuticals Private Limited, Pinakin Pharmaceuticals Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).
Devesh Kumar Rai was appointed as Director on 05 Mar 2019. Saurabh Kumar Rai was appointed as Director on 05 Mar 2019.
Yes, Eligens Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-UP-55-0001071).
The registered office of Eligens Pharmaceuticals is at 5288 Vipul Khand Gomti Nagar, Lucknow, Uttar Pradesh, India – 226010.
Eligens Pharmaceuticals operates in the chemicals industry, in the fine chemicals and other chemical products segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages